Hiram S. Cody III, MD, FACS

About Me

My surgical practice and clinical research focus entirely on the treatment of breast cancer. My research interests have included patterns of loco-regional spread, long-term outcomes of breast cancer surgery, the impact of screening mammography, and, most recently, sentinel lymph node biopsy. This procedure involves removing the first few lymph nodes draining from the breast (“sentinel nodes”) and checking for the presence of cancer. If the sentinel nodes are cancer free, then the remaining nodes don’t need to be removed and the side effects of the lymph node surgery are minimized. My colleagues and I continue to study and refine the procedure; we have presented and published our work worldwide and have taught sentinel node biopsy to hundreds of practicing surgeons and trainees. An exciting recent development has been the demonstration by our group and others that even when the sentinel nodes contain cancer, many patients do not require additional lymph node surgery.

I have been the Principal Investigator of Memorial Sloan Kettering’s Sentinel Lymph Node Biopsy Program, have served as Acting Chief of the Breast Service (1996-98), and am active in local, national, and international organizations. I am a Past-President of the American Society of Breast Surgeons and of the New York Metropolitan Breast Cancer Group. I am Editor of the journal Breast Diseases and do peer review for 15 other journals. I lecture widely and am the editor of the multi-author textbook Sentinel Lymph Node Biopsy.    

  • Clinical Expertise: Breast Cancer; Sentinel Node Biopsy
  • Languages Spoken: English
  • Education: MD, Columbia University
  • Residencies: General Surgery - Roosevelt Hospital
  • Fellowships: Surgical Oncology - Memorial Sloan Kettering Cancer Center
  • Board Certifications: Surgery

See My Colleagues


Visit PubMed for a full listing of Hiram S. Cody III’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.